ClinicaliQ Trial Snapshot
- Post-Market Clinical Follow Up Study With Navitor Valve — Recruiting • Cardiology / Cardiovascular • NCT06008080.
- What is being tested: The Navitor TAVI (Transcatheter Aortic Valve Implantation) System is undergoing post-market evaluation to assess its safety profile and clinical performance in real-world patient populations following commercial approval.
- Patient eligibility overview: The study includes patients with aortic valve disease who are candidates for transcatheter aortic valve replacement, with eligibility determined by standard TAVI assessment criteria and participating centre protocols across the global study sites.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
Evaluation of the safety and performance of the Navitor TAVI System in a Global Study
Eligibility Snapshot
- : * Patient is eligible per the current approved indication after Heart Team discussion and intended to undergo a Navitor TAVI procedure. * The patient has been informed of the nature of the study, agrees to its provisions, and has provided written informed consent as approved by the IRB (Investigational Review Board)/EC (Ethics Committee) of the respective clinical site. * The patient and the treating physician agree that the subject will return for all required post procedure follow up visits.
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.